Free Trial

Cogent Biosciences (COGT) SEC Filings & 10K Form

Cogent Biosciences logo
$7.14 -0.15 (-2.11%)
Closing price 03:58 PM Eastern
Extended Trading
$7.14 +0.00 (+0.06%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cogent Biosciences SEC Filings

DateFilerForm TypeView
02/28/2025
7:00 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
4:20 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
JB CAPITAL PARTNERS LP (Filed by)
Form SCHEDULE 13G/A
01/22/2025
8:50 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
GEYGAN JAMES (Reporting)
GEYGAN JEFFREY RICHART (Reporting)
Geygan Kathleen (Reporting)
GLOBAL VALUE INVESTMENT CORP. (Reporting)
Rice Shawn G (Reporting)
Wilke Stacy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:02 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
GLOBAL VALUE INVESTMENT CORP. (Filed by)
Form SCHEDULE 13D/A
01/17/2025
1:05 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
3:16 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
1:58 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
11:10 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4/A
12/06/2024
11:11 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
12/06/2024
11:12 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4/A
12/06/2024
11:13 AM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4/A
12/04/2024
1:33 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
1:35 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
1:37 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
1:43 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:49 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
GEYGAN JAMES (Reporting)
GEYGAN JEFFREY RICHART (Reporting)
Geygan Kathleen (Reporting)
GLOBAL VALUE INVESTMENT CORP. (Reporting)
Rice Shawn G (Reporting)
Wilke Stacy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/03/2024
4:15 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
GLOBAL VALUE INVESTMENT CORP. (Filed by)
Form SC 13D/A
12/02/2024
5:40 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 424B5
12/02/2024
5:03 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
3:32 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form NT 10-Q
11/15/2024
3:30 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/11/2024
4:36 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
1:26 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
11:15 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form EFFECT
08/27/2024
8:00 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/26/2024
4:18 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
FROST PHILLIP MD ET AL (Filed by)
Form SC 13D/A
08/23/2024
3:35 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
Form SC 13D/A
08/23/2024
3:36 PM
Conlin Matthew (Filed by)
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Form SC 13D/A
08/21/2024
1:24 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
10:59 AM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
11:01 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
11:03 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
11:04 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
11:20 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 10-Q/A
08/19/2024
4:13 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/19/2024
3:27 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
4:01 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form NT 10-Q
07/22/2024
3:52 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
Form SC 13D/A
07/17/2024
5:20 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:00 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
11:40 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
An AI warning from a Wall Street legend (Ad)

AI is creeping into every aspect of our daily lives… According to billion-dollar fund manager Louis Navellier, it's never been more important to AI-proof your wealth. He lays out three simple steps to take ASAP in his new video.

During the broadcast I go over a three-step action plan you can use to prepare for what's to come. C
07/08/2024
2:49 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
2:51 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
11:15 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
9:06 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
SHATTUCK KOHN BARBARA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
9:10 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Mathis Donald H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
9:13 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Graff David Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
9:15 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
PFENNIGER RICHARD C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
7:53 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:54 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:55 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:56 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:57 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:45 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
06/18/2024
3:43 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
11:14 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form DEFA14A
06/07/2024
10:35 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
4:27 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form DEF 14A
05/30/2024
3:45 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
05/23/2024
4:19 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form PRE 14A
05/20/2024
4:28 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
FROST PHILLIP MD ET AL (Filed by)
Form SC 13D/A
05/16/2024
7:02 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
11:21 AM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
Form SC 13D/A
05/16/2024
11:22 AM
Conlin Matthew (Filed by)
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Form SC 13D/A
05/15/2024
8:55 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:30 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
3:50 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
3:18 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
4:22 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
4:21 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form ARS
04/02/2024
3:21 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
4:18 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
5:01 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:57 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:COGT) was last updated on 3/14/2025 by MarketBeat.com Staff
From Our Partners